Based on the earnings transcript, Procter & Gamble (P&G) reported strong financial results for FY 2022, with organic sales growth of 7% and EPS growth of 3%. The company also provided guidance for FY 2023, projecting organic sales growth of 3% to 5% and EPS growth of 0% to 4%. The company's management highlighted the challenges posed by inflation, supply chain disruptions, and geopolitical tensions, but expressed confidence in their ability to navigate these headwinds. The stock is expected to experience short-term volatility due to the company's guidance and the broader market conditions.